The global vascular stents market size reached a value of almost USD 10.57 billion in the year 2023. The vascular stents industry is further expected to grow at a CAGR of 5.5% between 2024 and 2032 to reach a value of almost USD 17.10 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global vascular stents market is driven by increasing preference for minimally invasive (MI) procedures all over the world. North America is the leading market for vascular stents in the world. This can be ascribed to rising obesity, changing food consumption patterns, and a rise in smoking and alcohol consumption across the region.
Vascular diseases are those diseases that are caused by abnormalities in blood vessels that result in blockage or damage. Some of the common vascular diseases include abdominal aortic aneurysm (AAA), peripheral arterial disease (PAD), coronary heart disease, and carotid artery disease (CAD).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is divided on the basis of type into:
Currently, the coronary type represents the most extensively used product type in the market.
On the basis of material, the market is segmented into:
Metallic stents are further divided on the basis of type into cobalt chromium, platinum chromium, nickel titanium, and stainless steel.
On the basis of mode of delivery, the market is bifurcated into:
At present, balloon-expandable stents account for the majority of the total market share.
On the basis of end-uses, the market is divided into:
Out of these, hospitals and cardiac centres hold the dominant market share.
The report also covers the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global vascular stents market is driven by the rising geriatric population across the globe. In addition to this, the rising incidences of coronary artery disease have led to the growing need for heart stent surgeries. This can be attributed to unhealthy eating habits, lack of physical activity, and the increased intake of alcohol, particularly among the young population. Moreover, the growing preference for minimally invasive (MI) procedures is also providing impetus to the market growth as they ensure a fast recovery. The vascular stents market is further supported by several factors such as minimised bleeding, low risk of infection, and low cost of the product in comparison to conventional surgical methods.
The report gives a detailed analysis of the following key players in the global vascular stents market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type
|Breakup by Product Type
|Breakup by Material
|Breakup by Mode of Delivery
|Breakup by End User
|Breakup by Region
|Report Price and Purchase Option
|Explore our purchase options that are best suited to your resources and industry needs.
|Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Vascular Stents Market Overview
3.1 Global Vascular Stents Market Historical Value (2017-2023)
3.2 Global Vascular Stents Market Forecast Value (2024-2032)
4 Global Vascular Stents Market Landscape
4.1 Global Vascular Stents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Vascular Stents Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Product Type
4.2.3 Analysis by Material
4.2.4 Analysis by Mode of Delivery
4.2.5 Analysis by End User
5 Global Vascular Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Vascular Stents Market Segmentation
6.1 Global Vascular Stents Market by Type
6.1.1 Market Overview
6.1.2 Drug-Eluting Stents
6.1.3 Bare-Metal Stents
6.1.4 Bio absorbable Stents
6.2 Global Vascular Stents Market by Product Type
6.2.1 Market Overview
6.2.2 Coronary Stents
6.2.3 Peripheral Vascular Stents
6.2.4 Evar Stent Grafts
6.3 Global Vascular Stents Market by Material
6.3.1 Market Overview
6.3.2 Metallic Stents
184.108.40.206 Cobalt Chromium
220.127.116.11 Platinum Chromium
18.104.22.168 Nickel Chromium
22.214.171.124 Stainless Steel
6.4 Global Vascular Stents Market by Mode of Delivery
6.4.1 Market Overview
6.4.2 Balloon - Expandable Stents
6.4.3 Self - Expanding Stents
6.5 Global Vascular Stents Market by End User
6.5.1 Market Overview
6.5.2 Hospital and Cardiac Centres
6.5.3 Ambulatory Surgical Centres
6.6 Global Vascular Stents Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Vascular Stents Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Vascular Stents Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Vascular Stents Market
9.1 Market Share by Country
10 Latin America Vascular Stents Market
10.1 Market Share by Country
11 Middle East and Africa Vascular Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Biotronik, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 MicroPort Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 B. Braun Melsungen AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Terumo Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Meril Life Sciences Pvt. Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Biosensors International Group, Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Lepu Medical Technology
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Koninklijke Philips N.V.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Teleflex Incorporated.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
18 Global Vascular Stents Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2023, the global vascular stents market attained a value of nearly USD 10.57 billion.
The market is projected to grow at a CAGR of 5.5% between 2024 and 2032.
The market is estimated to grow in the forecast period of 2024-2032 to reach about USD 17.10 billion by 2032.
The major drivers of the industry, such as increasing demand for minimally invasive surgeries, growing geriatric population, increased prevalence of coronary artery diseases, and increasing consumption of alcohol, particularly among the young population, are expected to aid the market growth.
The key market trends guiding the growth of the vascular stents market include growing technological advancements and the low cost of the product than conventional surgical procedures.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The coronary stents segment is the leading product-type of vascular stents in the industry.
The major material-types available in the industry are metallic stents and others, where the former segment includes materials like cobalt chromium, platinum chromium, nickel titanium, and stainless steel.
The balloon-expandable stents segment is the leading mode of delivery in the industry.
The hospitals and cardiac centres segment is the leading end-use segment of vascular stents.
The major players in the industry are Abbott Laboratories, Boston Scientific Corporation, Biotronik, Inc., MicroPort Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, and Meril Life Sciences Pvt. Ltd., among others.
The global vascular stents market attained a value of USD 10.57 billion in 2023, driven by the rising incidences of coronary artery diseases among the growing geriatric population, coupled with the increased demand for minimally invasive surgeries. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5.5%. The market is projected to reach USD 17.10 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product-types, the vascular stents industry can be segmented into coronary stents, peripheral vascular stents, EVAR stent grafts, and others, with coronary stents accounting for the largest market share. On the basis of material, the industry is divided into metallic stents and others. On the basis of mode of delivery, the industry can be categorised into balloon-expandable and self-expanding stents. On the basis of end-use sectors, the industry is bifurcated into hospitals and cardiac centres and ambulatory surgical centres, where hospitals and cardiac centres segment accounts for the leading share in the industry. The major regional markets for vascular stents are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include Abbott Laboratories, Boston Scientific Corporation, Biotronik, Inc., MicroPort Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, and Meril Life Sciences Pvt. Ltd., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.